Investor Relations

Investor Relations

Events

Email Alerts
Past Events
 Friday, May 21, 2021
Chemomab to present at Oppenheimer Rare & Orphan Disease Summit
 Sunday, March 21, 2021
Chemomab to participate at the BIO-Europe Spring Digital Conference | March 22-25, 2021.
 Tuesday, March 16, 2021 -
Thursday, March 18, 2021
Chemomab to present at Oppenheimer 31st Annual Healthcare Conference I March 16-18, 2021. Dr. Adi Mor, CEO virtual presentation is scheduled for Thursday, March 18, 2021 at 8:00 AM - 8:30 AM (ET).
 Tuesday, March 9, 2021
Chemomab to present at H.C. Wainwright Global Life Sciences Conference I March 9-10, 2021. On-demand presentation by Dr. Adi Mor, CEO will be available through the conference.
 Monday, February 15, 2021
Chemomab to participate at the BIO CEO & Investor Digital Conference | February 16-18, 2021. We will be available for virtual one-on-one meetings with investors and strategic pharma partners
 Monday, January 11, 2021
Chemomab to present at H.C. Wainwright BioConnect 2021 Virtual Conference (January 11-15). We will available for 1x1 meetings with investors who are registered to attend the conference.
 Monday, January 11, 2021
Chemomab to participate virtually JPM week (January 11-15, 2021). We will be available for virtual one-on-one meetings with investors and strategic pharma partners using BIO One-on-One Partnering™
 Monday, December 14, 2020
Chemomab to participate at SVB Leerink's Biopharma Private Company Connect (December 15th -17th, 2020). We will be available for virtual one-on-one meetings with investors who are registered to attend the conference.
 Tuesday, November 17, 2020
Chemomab to participate at the 11th Annual Jefferies Virtual Global Healthcare Conference (November 17-19, 2020). Adi Mor, CEO, will be available to participate in a virtual one-on-one meetings with investors who are registered to attend the conference.
 Monday, November 16, 2020
Chemomab to present at the Stifel 2020 Virtual Healthcare Conference (November 16, 2020 at 8:40 EST). Adi Mor, CEO, will present Chemomab’s overview and will be available to participate in a virtual one-on-one meetings with investors who are registered...